Compare Davita Inc (DVA) vs Global X NASDAQ 100 Covered Call ETF (QYLD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Davita Inc vs Global X NASDAQ 100 Covered Call ETF — how do they compare? Davita Inc trades at $175.04 (market cap $11.29B), while Global X NASDAQ 100 Covered Call ETF trades at $18.69 (market cap $8.49B). The key difference: Davita Inc is the larger of the two by market cap, and Global X NASDAQ 100 Covered Call ETF is trading nearer its 52-week high, Davita Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Davita Inc for 113 Days and Global X NASDAQ 100 Covered Call ETF for 50 Days on average.
| DVA | QYLD | |
|---|---|---|
Market Cap | $11.29B | $8.49B |
Volume | 582,204 | 2,913,938 |
Sector | Health | Income / Options Overlay |
52-Week High | $240.96 | $18.68 |
52-Week Low | $103.87 | $16.70 |
Typical Hold Time | 113 Days | 50 Days |
Enterprise Value | $24.01B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DaVita (DVA) trades at $176.78, down 2.01% today, showing technical bearish signals with price near key support at $175. Fundamentally, the company demonstrates solid earnings performance with three consecutive quarterly beats and attractive valuation metrics including a P/E of 14.98 and P/S of 0.88. Recent expansion of value-based care partnerships with Humana positions the company for continued growth in kidney care services.
The stock presents a compelling value opportunity with analyst consensus target of $235.67 offering 33% upside potential, though investors face risks from regulatory pressures and narrowing profit margins. Warren Buffett's significant ownership (45%) and institutional buying activity provide confidence, but the bearish technical outlook and mixed analyst ratings (43% Buy, 52% Hold) suggest cautious optimism is warranted.
QYLD trades at $18.68 with no recent price movement, maintaining a stable position amidst mixed technical signals. The ETF shows a bullish moving average trend but bearish oscillators, with RSI indicating potential overbought conditions. Recent dividend distributions of $0.18 per share demonstrate consistent income generation, though news coverage highlights concerns about long-term capital erosion and tax implications of the covered call strategy.
The outlook for QYLD remains income-focused with limited growth potential. While the 12% yield provides attractive monthly cash flow, the strategy caps upside participation in Nasdaq rallies. Key risks include declining option premiums, distribution sustainability concerns, and ordinary income tax treatment that may surprise investors expecting return-of-capital benefits.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Davita Inc
DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,100 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives approximately 69% of U.S. sales at government (primarily Medicare) reimbursement rates, with the remaining 31% coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.
Read more on DVA →About Global X NASDAQ 100 Covered Call ETF
QYLD is an ETF that follows a covered call strategy on the NASDAQ 100 Index. The fund holds a long position in the stocks of the NASDAQ 100 and simultaneously writes (sells) call options on the index. The primary goal is to generate monthly income from the option premiums. This strategy can reduce portfolio volatility and provide income, but it limits potential capital appreciation from a significant rise in the NASDAQ 100 Index.
Read more on QYLD →
